KAITLYN FRENCH: Open Payments
NPI 1972018166 · GREENVALE, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,341 in 62 payments from 21 companies in 2025. Trend: 2023 $1,257 · 2024 $1,458 · 2025 $1,341
Food & beverage: $1,341
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 8 | $161 |
| Amgen Inc. | 8 | $154 |
| Novartis Pharmaceuticals Corporation | 6 | $111 |
| PFIZER INC. | 5 | $100 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $95 |
| Lilly USA, LLC | 4 | $93 |
| Novo Nordisk Inc | 3 | $81 |
| SCPHARMACEUTICALS INC. | 3 | $76 |
| AstraZeneca Pharmaceuticals LP | 3 | $57 |
| Esperion Therapeutics, Inc. | 3 | $50 |
Products named: ELIQUIS, REPATHA, JARDIANCE, LEQVIO, ZEPBOUND, CAMZYOS, FUROSCIX, NEXLETOL.
Industry payments across NY — which companies pay providers there.
